352 related articles for article (PubMed ID: 9425908)
41. ZNF198 protein, involved in rearrangement in myeloproliferative disease, forms complexes with the DNA repair-associated HHR6A/6B and RAD18 proteins.
Kunapuli P; Somerville R; Still IH; Cowell JK
Oncogene; 2003 May; 22(22):3417-23. PubMed ID: 12776193
[TBL] [Abstract][Full Text] [Related]
42. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
43. ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5.
Smedley D; Demiroglu A; Abdul-Rauf M; Heath C; Cooper C; Shipley J; Cross NC
Neoplasia; 1999 Oct; 1(4):349-55. PubMed ID: 10935490
[TBL] [Abstract][Full Text] [Related]
44. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
[TBL] [Abstract][Full Text] [Related]
45. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33).
Guasch G; Mack GJ; Popovici C; Dastugue N; Birnbaum D; Rattner JB; Pébusque MJ
Blood; 2000 Mar; 95(5):1788-96. PubMed ID: 10688839
[TBL] [Abstract][Full Text] [Related]
46. A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12).
Invernizzi R; Benatti C; Travaglino E; Girino M; Bernasconi P; Loni C; Ascari E
Haematologica; 2004 Feb; 89(2):239-41. PubMed ID: 15003903
[No Abstract] [Full Text] [Related]
47. Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation.
Yagasaki F; Wakao D; Yokoyama Y; Uchida Y; Murohashi I; Kayano H; Taniwaki M; Matsuda A; Bessho M
Cancer Res; 2001 Dec; 61(23):8371-4. PubMed ID: 11731410
[TBL] [Abstract][Full Text] [Related]
48. Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation.
Ollendorff V; Guasch G; Isnardon D; Galindo R; Birnbaum D; Pébusque MJ
J Biol Chem; 1999 Sep; 274(38):26922-30. PubMed ID: 10480903
[TBL] [Abstract][Full Text] [Related]
49. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.
Kumar KR; Chen W; Koduru PR; Luu HS
Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510
[TBL] [Abstract][Full Text] [Related]
50. Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: a case report.
Sahin F; Sercan Z; Ertan Y; Ocakci S; Ay E; Vural F; Yuksel E; Tombuloglu M; Saydam G
Hematology; 2007 Dec; 12(6):489-92. PubMed ID: 17852454
[TBL] [Abstract][Full Text] [Related]
51. The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13.
Still IH; Cowell JK
Blood; 1998 Aug; 92(4):1456-8. PubMed ID: 9694738
[No Abstract] [Full Text] [Related]
52. [The 8p11 myeloproliferative syndrome].
Reither A; Hehlmann R; Goldman JM; Cross NC
Med Klin (Munich); 1999 Apr; 94(4):207-10. PubMed ID: 10373756
[TBL] [Abstract][Full Text] [Related]
53. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature.
Wakim JJ; Tirado CA; Chen W; Collins R
Leuk Res; 2011 Sep; 35(9):e151-3. PubMed ID: 21628071
[No Abstract] [Full Text] [Related]
54. 8p11 Myeloproliferative syndrome with BCR-FGFR1 rearrangement presenting with T-lymphoblastic lymphoma and bone marrow stromal cell proliferation: a case report and review of the literature.
Kim SY; Oh B; She CJ; Kim HK; Jeon YK; Shin MG; Yoon SS; Lee DS
Leuk Res; 2011 May; 35(5):e30-4. PubMed ID: 21239058
[No Abstract] [Full Text] [Related]
55. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.
Agerstam H; Järås M; Andersson A; Johnels P; Hansen N; Lassen C; Rissler M; Gisselsson D; Olofsson T; Richter J; Fan X; Ehinger M; Fioretos T
Blood; 2010 Sep; 116(12):2103-11. PubMed ID: 20554971
[TBL] [Abstract][Full Text] [Related]
56. Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase.
Ren M; Li X; Cowell JK
Blood; 2009 Aug; 114(8):1576-84. PubMed ID: 19506298
[TBL] [Abstract][Full Text] [Related]
57. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
[TBL] [Abstract][Full Text] [Related]
58. [8p11 myeloproliferative syndrome].
Li F; Zhai YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1073-7. PubMed ID: 23998615
[TBL] [Abstract][Full Text] [Related]
59. Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion.
Dolan M; Cioc A; Cross NC; Neglia JP; Tolar J
Pediatr Blood Cancer; 2012 Jul; 59(1):194-6. PubMed ID: 22106025
[TBL] [Abstract][Full Text] [Related]
60. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia.
Mikhail FM; Coignet L; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Farahat N; Nucifora G
Genes Chromosomes Cancer; 2004 Feb; 39(2):110-8. PubMed ID: 14695990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]